• Journal of Electrical Engineering and Technology
• /
• 제10권3호
• /
• pp.990-1001
• /
• 2015

This paper presents analysis of Switched Reluctance Machine (SRM) using Geometry Based Analytical Model (GBAM), Finite Element Analysis (FEA) and Fourier Series Model (FSM) with curve fitting technique. Further a Transient Analysis (TA) technique is proposed to corroborate the analysis. The main aim of this paper is to give in depth procedure in developing a Geometry Based Analytical Model of Switched Reluctance Machine which is very accurate and simple. The GBAM is developed for the specifications obtained from the manufacturer and magnetizing characteristic of the material used for the construction. Precise values of the parameters like Magneto Motive Force (MMF), flux linkage, inductance and torque are obtained for various rotor positions taking into account the Fringing Effect (FE). The FEA model is developed using MagNet7.1.1 for the same machine geometry used in GBAM and the results are compared with GBAM. Further another analytical model called Fourier Series Model is developed to justify the accuracy of the results obtained by the methods GBAM and FEA model. A prototype of microcontroller based SRM drive system is constructed for validating the analysis and the results are reported.

• 터널과지하공간
• /
• 제18권1호
• /
• pp.44-57
• /
• 2008

본 연구에서는 암반의 수리적 거동을 다공성매체로 간주하고 개별균열 연결망을 통해 구해진 암반의 등가수리전도도와 수리이방성을 입력 자료로 하여 유한요소법 프로그램을 사용한 2차원 수리해석을 수행하였다. 입력변수에 의한 결정론적인 해를 얻게 되는 연속체 해석의 단점과 입력자료의 불확실성을 보완하기 위하여 입력변수에 대한 민감도 분석을 실시하고, 터널과 단층파쇄대의 다양한 위치관계를 고려한 가상의 시나리오 단면에 대하여 해석을 수행하였다. 이때 암반의 포화 불포화 특성을 반영하기 위한 수리전도도함수와 체적함수율 함수를 구하여 해석에 반영하였다. 해석대상지역은 경부고속철도 13-3공구, 원효터널의 고산 습지(무제치 3늪, 대성뒷늪, 대성큰늪) 하부통과구간과 간천계곡하부 통과구간으로서 부정류 해석을 통하여 터널 굴착 후 10년 경과시까지의 터널 내 유입수량과 인접지역의 지하수위를 살펴봄으로써 수리학적 안정성과 습지 및 계곡에 미치는 영향을 검토하였다. 그라우팅을 시행하지 않은 경우에는 무제치늪과 대성뒷늪 주변의 지하수위가 강하하지만, 그라우팅을 통해 수리전도도를 1/50 이하로 감소시킬 경우 지하수위는 강하하지 않는 것으로 나타났다. 그리고 단층파쇄대가 터널에 인접하여 위치하더라도 터널을 관통하지 않는 경우에는 단층파쇄대가 터널내 유입수량에 미치는 영향은 크지 않은 것으로 나타났다.

• 한국수정란이식학회:학술대회논문집
• /
• 한국수정란이식학회 2002년도 국제심포지엄
• /
• pp.97-97
• /
• 2002

Human eryhropoietin (EPO) is acidic glycoprotein hormone that plays key role in hematopoiesis by facilitating differentiation of erythrocyte and formation of hemoglobin (Hb) and is used for the treatment of anemia. Human EPO is consist of 166 amino acids which is modified by three N-glycosylations (24, 38, 83) and single O-glycosylation (126). N-glycosylation is reported to be related to the cellular secretion and activity of EPO. In this study, we examined effects of mutagenesis in glycosylation site of recombinat hEPO for the cellular secretion during production from cultured CHO cell. We produced rhEpo which was cloned by PCR from human liver cDNA (TaKaRa) in cultured CHO cell. Using supernatant of the culture, ELISA assay and western analysis were performed. To estimate biological activity, 20IU of rhuEpo was subcutaneously injected into four ICR mice. After 8 days, HCT level was increased average 13 per cent, RBC was increased ca. 2${\times}$10$\^$6//${\mu}\ell$. In disease model Rat (anemia c-kit, WSRC-WS/WS), HCT was increased ca. 12%, RBC was increased ca. 1.6${\times}$10$\^$6//${\mu}\ell$. These results suggests that rhEpo we produced has biological activity. To remove glycosylation site by substituting 24, 38, 83, and 126th asparagine (or serine) with glutamic acid, overlapping -extension site-directed mutagenesis was performed. To add novel glycosylation sites, 69, 105th leucine was mutated to asparagine. Mutant EPO construct was transfected into CHO cell. Supernatant of the cell culture was analyzed using ELISA assay with monoclonal anti-EPO antibody (Medac, Germany). Since, several reports for mutagenesis of glycosylation sites showed case-by-case results, we examined both transient expression and stable expression. Addition of novel glycosylation sites resulted no secretion while deletion mutants had little effect except some double deletion mutants (24/83 and 38/83) and triple mutant. We suggest that not single but combination of glycosyl group affect secretion of EPO.